so what's COH's purpose? pure research for academic paper? Can they overcome both IP and orphan drug designation? Can FDA or IP office reward them the IP from RAC due to "significant improvement in cancer drug developement and excellence for break-though contribution to human kind"?
COH is well funded for b-drug and plans to start trial which indeed concerns me.
I feel either they are idiots or we are idiots
RAC - Charts & Price Action, page-232
-
- There are more pages in this discussion • 21,297 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.82 |
Change
-0.005(0.27%) |
Mkt cap ! $309.9M | |||
| Open | High | Low | Value | Volume |
| $1.83 | $1.86 | $1.79 | $157.7K | 86.21K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5623 | $1.79 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.82 | 9999 | 1 |
View Market Depth
| Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |